Racial and Ethnic Differences in the Polycystic Ovary Syndrome (PCOS) Metabolic Phenotype

Lawrence Engmann, Susan Jin, Fangbai Sun, Richard S. Legro, Alex J. Polotsky, Karl R Hansen, Christos Coutifaris, Michael P Diamond, Esther Eisenberg, Heping Zhang, Nanette Santoro, Reproductive Medicine Network

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

BACKGROUND: Women with polycystic ovarian syndrome have a high prevalence of metabolic syndrome and type 2 diabetes mellitus. Blacks and Hispanics have a high morbidity and mortality due to cardiovascular disease and diabetes mellitus in the general population. Since metabolic syndrome is a risk factor for development of type 2 diabetes and cardiovascular disease, understanding any racial and ethnic differences in metabolic syndrome amongst women with polycystic ovarian syndrome is important for prevention strategies. However, data regarding racial/ethnic differences in metabolic phenotype amongst women with polycystic ovary syndrome is inconsistent.

OBJECTIVE: To determine if there are racial/ethnic differences in insulin resistance, metabolic syndrome and hyperandrogenemia in women with polycystic ovarian syndrome.

STUDY DESIGN: Secondary data analysis of a prospective multicenter, double blind controlled clinical trial, the Pregnancy in Polycystic Ovary Syndrome II study, conducted in 11 academic health centers. Data on 702 women with polycystic ovarian syndrome aged 18-40 years who met modified Rotterdam criteria for the syndrome and wished to conceive were included in the study. Women were grouped into racial/ethnic categories: Non-Hispanic Whites , non-Hispanic Blacks and Hispanic. The main outcomes were the prevalence of insulin resistance, metabolic syndrome and hyperandrogenemia in the different racial/ethnic groups.

RESULTS: BMI (35.1 ± 9.8 vs. 35.7 ± 7.9 vs. 36.4 ± 7.9 kg/m(2)) and waist circumference (106.5 ± 21.6 vs. 104.9 ± 16.4 vs. 108.7 ± 7.3 cm) did not differ significantly between non-Hispanic White, non-Hispanic Black and Hispanic women. Hispanic women with PCOS had a significantly higher prevalence of hirsutism (93.8 vs. 86.8%), abnormal free androgen index (FAI) (75.8 vs. 56.5%), abnormal homeostasis model assessment (HOMA) (52.3 vs. 38.4%) and hyperglycemia (14.8 vs. 6.5%), as well as lower sex hormone binding globulin compared to non-Hispanic Whites. Non-Hispanic Black women had a significantly lower prevalence of metabolic syndrome (24.5 vs. 42.2%) compared with Hispanic women, and lower serum triglyceride levels compared to both Hispanics and non-Hispanic Whites (85.7 ± 37.3 vs. 130.2 ± 57.0 vs. 120.1 ± 60.5 vs. mg/dL, p<0.01), with a markedly lower prevalence of hypertriglyceridemia (5.1 vs. 28.3 vs. 30.5%, p<0.01) compared to the other two groups.

COMMENT: Hispanic women with PCOS have the most severe phenotype, both in terms of hyperandrogenism and metabolic criteria. Non-Hispanic Black women have an overall milder polycystic ovarian syndrome phenotype than Hispanics and in some respects, than Non-Hispanic White women.

Original languageEnglish (US)
JournalAmerican Journal of Obstetrics and Gynecology
DOIs
StateE-pub ahead of print - Jan 16 2017
Externally publishedYes

Fingerprint

Polycystic Ovary Syndrome
Phenotype
Hispanic Americans
Type 2 Diabetes Mellitus
Insulin Resistance
Cardiovascular Diseases
Hyperandrogenism
Hirsutism
Sex Hormone-Binding Globulin
Hypertriglyceridemia
Controlled Clinical Trials
Waist Circumference
Ethnic Groups
Hyperglycemia
Androgens
Diabetes Mellitus
Triglycerides
Homeostasis

Cite this

Engmann, L., Jin, S., Sun, F., Legro, R. S., Polotsky, A. J., Hansen, K. R., ... Reproductive Medicine Network (2017). Racial and Ethnic Differences in the Polycystic Ovary Syndrome (PCOS) Metabolic Phenotype. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2017.01.003

Racial and Ethnic Differences in the Polycystic Ovary Syndrome (PCOS) Metabolic Phenotype. / Engmann, Lawrence; Jin, Susan; Sun, Fangbai; Legro, Richard S.; Polotsky, Alex J.; Hansen, Karl R; Coutifaris, Christos; Diamond, Michael P; Eisenberg, Esther; Zhang, Heping; Santoro, Nanette; Reproductive Medicine Network.

In: American Journal of Obstetrics and Gynecology, 16.01.2017.

Research output: Contribution to journalArticle

Engmann, L, Jin, S, Sun, F, Legro, RS, Polotsky, AJ, Hansen, KR, Coutifaris, C, Diamond, MP, Eisenberg, E, Zhang, H, Santoro, N & Reproductive Medicine Network 2017, 'Racial and Ethnic Differences in the Polycystic Ovary Syndrome (PCOS) Metabolic Phenotype', American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2017.01.003
Engmann, Lawrence ; Jin, Susan ; Sun, Fangbai ; Legro, Richard S. ; Polotsky, Alex J. ; Hansen, Karl R ; Coutifaris, Christos ; Diamond, Michael P ; Eisenberg, Esther ; Zhang, Heping ; Santoro, Nanette ; Reproductive Medicine Network. / Racial and Ethnic Differences in the Polycystic Ovary Syndrome (PCOS) Metabolic Phenotype. In: American Journal of Obstetrics and Gynecology. 2017.
@article{bcc35ae634fd4b33ae1edab581d2a660,
title = "Racial and Ethnic Differences in the Polycystic Ovary Syndrome (PCOS) Metabolic Phenotype",
abstract = "BACKGROUND: Women with polycystic ovarian syndrome have a high prevalence of metabolic syndrome and type 2 diabetes mellitus. Blacks and Hispanics have a high morbidity and mortality due to cardiovascular disease and diabetes mellitus in the general population. Since metabolic syndrome is a risk factor for development of type 2 diabetes and cardiovascular disease, understanding any racial and ethnic differences in metabolic syndrome amongst women with polycystic ovarian syndrome is important for prevention strategies. However, data regarding racial/ethnic differences in metabolic phenotype amongst women with polycystic ovary syndrome is inconsistent.OBJECTIVE: To determine if there are racial/ethnic differences in insulin resistance, metabolic syndrome and hyperandrogenemia in women with polycystic ovarian syndrome.STUDY DESIGN: Secondary data analysis of a prospective multicenter, double blind controlled clinical trial, the Pregnancy in Polycystic Ovary Syndrome II study, conducted in 11 academic health centers. Data on 702 women with polycystic ovarian syndrome aged 18-40 years who met modified Rotterdam criteria for the syndrome and wished to conceive were included in the study. Women were grouped into racial/ethnic categories: Non-Hispanic Whites , non-Hispanic Blacks and Hispanic. The main outcomes were the prevalence of insulin resistance, metabolic syndrome and hyperandrogenemia in the different racial/ethnic groups.RESULTS: BMI (35.1 ± 9.8 vs. 35.7 ± 7.9 vs. 36.4 ± 7.9 kg/m(2)) and waist circumference (106.5 ± 21.6 vs. 104.9 ± 16.4 vs. 108.7 ± 7.3 cm) did not differ significantly between non-Hispanic White, non-Hispanic Black and Hispanic women. Hispanic women with PCOS had a significantly higher prevalence of hirsutism (93.8 vs. 86.8{\%}), abnormal free androgen index (FAI) (75.8 vs. 56.5{\%}), abnormal homeostasis model assessment (HOMA) (52.3 vs. 38.4{\%}) and hyperglycemia (14.8 vs. 6.5{\%}), as well as lower sex hormone binding globulin compared to non-Hispanic Whites. Non-Hispanic Black women had a significantly lower prevalence of metabolic syndrome (24.5 vs. 42.2{\%}) compared with Hispanic women, and lower serum triglyceride levels compared to both Hispanics and non-Hispanic Whites (85.7 ± 37.3 vs. 130.2 ± 57.0 vs. 120.1 ± 60.5 vs. mg/dL, p<0.01), with a markedly lower prevalence of hypertriglyceridemia (5.1 vs. 28.3 vs. 30.5{\%}, p<0.01) compared to the other two groups.COMMENT: Hispanic women with PCOS have the most severe phenotype, both in terms of hyperandrogenism and metabolic criteria. Non-Hispanic Black women have an overall milder polycystic ovarian syndrome phenotype than Hispanics and in some respects, than Non-Hispanic White women.",
author = "Lawrence Engmann and Susan Jin and Fangbai Sun and Legro, {Richard S.} and Polotsky, {Alex J.} and Hansen, {Karl R} and Christos Coutifaris and Diamond, {Michael P} and Esther Eisenberg and Heping Zhang and Nanette Santoro and {Reproductive Medicine Network}",
note = "Copyright {\circledC} 2017. Published by Elsevier Inc.",
year = "2017",
month = "1",
day = "16",
doi = "10.1016/j.ajog.2017.01.003",
language = "English (US)",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Racial and Ethnic Differences in the Polycystic Ovary Syndrome (PCOS) Metabolic Phenotype

AU - Engmann, Lawrence

AU - Jin, Susan

AU - Sun, Fangbai

AU - Legro, Richard S.

AU - Polotsky, Alex J.

AU - Hansen, Karl R

AU - Coutifaris, Christos

AU - Diamond, Michael P

AU - Eisenberg, Esther

AU - Zhang, Heping

AU - Santoro, Nanette

AU - Reproductive Medicine Network

N1 - Copyright © 2017. Published by Elsevier Inc.

PY - 2017/1/16

Y1 - 2017/1/16

N2 - BACKGROUND: Women with polycystic ovarian syndrome have a high prevalence of metabolic syndrome and type 2 diabetes mellitus. Blacks and Hispanics have a high morbidity and mortality due to cardiovascular disease and diabetes mellitus in the general population. Since metabolic syndrome is a risk factor for development of type 2 diabetes and cardiovascular disease, understanding any racial and ethnic differences in metabolic syndrome amongst women with polycystic ovarian syndrome is important for prevention strategies. However, data regarding racial/ethnic differences in metabolic phenotype amongst women with polycystic ovary syndrome is inconsistent.OBJECTIVE: To determine if there are racial/ethnic differences in insulin resistance, metabolic syndrome and hyperandrogenemia in women with polycystic ovarian syndrome.STUDY DESIGN: Secondary data analysis of a prospective multicenter, double blind controlled clinical trial, the Pregnancy in Polycystic Ovary Syndrome II study, conducted in 11 academic health centers. Data on 702 women with polycystic ovarian syndrome aged 18-40 years who met modified Rotterdam criteria for the syndrome and wished to conceive were included in the study. Women were grouped into racial/ethnic categories: Non-Hispanic Whites , non-Hispanic Blacks and Hispanic. The main outcomes were the prevalence of insulin resistance, metabolic syndrome and hyperandrogenemia in the different racial/ethnic groups.RESULTS: BMI (35.1 ± 9.8 vs. 35.7 ± 7.9 vs. 36.4 ± 7.9 kg/m(2)) and waist circumference (106.5 ± 21.6 vs. 104.9 ± 16.4 vs. 108.7 ± 7.3 cm) did not differ significantly between non-Hispanic White, non-Hispanic Black and Hispanic women. Hispanic women with PCOS had a significantly higher prevalence of hirsutism (93.8 vs. 86.8%), abnormal free androgen index (FAI) (75.8 vs. 56.5%), abnormal homeostasis model assessment (HOMA) (52.3 vs. 38.4%) and hyperglycemia (14.8 vs. 6.5%), as well as lower sex hormone binding globulin compared to non-Hispanic Whites. Non-Hispanic Black women had a significantly lower prevalence of metabolic syndrome (24.5 vs. 42.2%) compared with Hispanic women, and lower serum triglyceride levels compared to both Hispanics and non-Hispanic Whites (85.7 ± 37.3 vs. 130.2 ± 57.0 vs. 120.1 ± 60.5 vs. mg/dL, p<0.01), with a markedly lower prevalence of hypertriglyceridemia (5.1 vs. 28.3 vs. 30.5%, p<0.01) compared to the other two groups.COMMENT: Hispanic women with PCOS have the most severe phenotype, both in terms of hyperandrogenism and metabolic criteria. Non-Hispanic Black women have an overall milder polycystic ovarian syndrome phenotype than Hispanics and in some respects, than Non-Hispanic White women.

AB - BACKGROUND: Women with polycystic ovarian syndrome have a high prevalence of metabolic syndrome and type 2 diabetes mellitus. Blacks and Hispanics have a high morbidity and mortality due to cardiovascular disease and diabetes mellitus in the general population. Since metabolic syndrome is a risk factor for development of type 2 diabetes and cardiovascular disease, understanding any racial and ethnic differences in metabolic syndrome amongst women with polycystic ovarian syndrome is important for prevention strategies. However, data regarding racial/ethnic differences in metabolic phenotype amongst women with polycystic ovary syndrome is inconsistent.OBJECTIVE: To determine if there are racial/ethnic differences in insulin resistance, metabolic syndrome and hyperandrogenemia in women with polycystic ovarian syndrome.STUDY DESIGN: Secondary data analysis of a prospective multicenter, double blind controlled clinical trial, the Pregnancy in Polycystic Ovary Syndrome II study, conducted in 11 academic health centers. Data on 702 women with polycystic ovarian syndrome aged 18-40 years who met modified Rotterdam criteria for the syndrome and wished to conceive were included in the study. Women were grouped into racial/ethnic categories: Non-Hispanic Whites , non-Hispanic Blacks and Hispanic. The main outcomes were the prevalence of insulin resistance, metabolic syndrome and hyperandrogenemia in the different racial/ethnic groups.RESULTS: BMI (35.1 ± 9.8 vs. 35.7 ± 7.9 vs. 36.4 ± 7.9 kg/m(2)) and waist circumference (106.5 ± 21.6 vs. 104.9 ± 16.4 vs. 108.7 ± 7.3 cm) did not differ significantly between non-Hispanic White, non-Hispanic Black and Hispanic women. Hispanic women with PCOS had a significantly higher prevalence of hirsutism (93.8 vs. 86.8%), abnormal free androgen index (FAI) (75.8 vs. 56.5%), abnormal homeostasis model assessment (HOMA) (52.3 vs. 38.4%) and hyperglycemia (14.8 vs. 6.5%), as well as lower sex hormone binding globulin compared to non-Hispanic Whites. Non-Hispanic Black women had a significantly lower prevalence of metabolic syndrome (24.5 vs. 42.2%) compared with Hispanic women, and lower serum triglyceride levels compared to both Hispanics and non-Hispanic Whites (85.7 ± 37.3 vs. 130.2 ± 57.0 vs. 120.1 ± 60.5 vs. mg/dL, p<0.01), with a markedly lower prevalence of hypertriglyceridemia (5.1 vs. 28.3 vs. 30.5%, p<0.01) compared to the other two groups.COMMENT: Hispanic women with PCOS have the most severe phenotype, both in terms of hyperandrogenism and metabolic criteria. Non-Hispanic Black women have an overall milder polycystic ovarian syndrome phenotype than Hispanics and in some respects, than Non-Hispanic White women.

U2 - 10.1016/j.ajog.2017.01.003

DO - 10.1016/j.ajog.2017.01.003

M3 - Article

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

ER -